USA - engelsk - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum , trichophyton mentagrophytes , and trichophyton rubrum in patients 17 years and older. none. risk summary there are no available data on topical betamethasone dipropionate or clotrimazole use in pregnant women to identify a clotrimazole and betamethasone dipropionate cream associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of potent or very potent topical corticosteroid during pregnancy. advise pregnant women that clotrimazole and betamethasone dipropionate cream may increase the risk of having a low birthweight infant and to use clotrimazole and betamethasone dipropionate cream on the smallest area of skin and for the shortest

USA - engelsk - NLM (National Library of Medicine)

actavis pharma, inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes, and trichophyton rubrum in patients 17 years and older. none. risk summary there are no available data on topical betamethasone dipropionate or clotrimazole use in pregnant women to identify a clotrimazole and betamethasone dipropionate cream associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of potent or very potent topical corticosteroid during pregnancy. advise pregnant women that clotrimazole and betamethasone dipropionate cream may increase the risk of having a low birthweight infant and to use clotrimazole and betamethasone dipropionate cream on the smallest area of skin and for the shortest

USA - engelsk - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - clotrimazole 10 mg in 1 g - clotrimazole and betamethasone dipropionate cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to epidermophyton floccosum, trichophyton mentagrophytes, and trichophyton rubrum in patients 17 years and older. none. teratogenic effects pregnancy category c there are no adequate and well-controlled studies with clotrimazole and betamethasone dipropionate cream in pregnant women. therefore, clotrimazole and betamethasone dipropionate cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. there have been no teratogenic studies performed in animals or humans with the combination of clotrimazole and betamethasone dipropionate. corticosteroids are generally teratogenic in laboratory animals when administered at relatively low dosage levels. studies in pregnant rats with intravaginal doses up to 100 mg/kg (15 times the maximum

USA - engelsk - NLM (National Library of Medicine)

sola pharmaceuticals - clotrimazole (unii: g07gz97h65) (clotrimazole - unii:g07gz97h65) - antifungal

Malta - engelsk - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - vaginal tablet - clotrimazole 100 mg - gynecological antiinfectives and antiseptics

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

bayer hispania s.l. - clotrimazol - crema vaginal - 20 mg/g - clotrimazol 20 mg - clotrimazol

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

bayer hispania s.l. - clotrimazol - comprimido vaginal - 500 mg - clotrimazol 500 mg - clotrimazol

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

bayer hispania s.l. - clotrimazol - comprimido vaginal - 100 mg - clotrimazol 100 mg - clotrimazol

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

bayer hispania s.l. - clotrimazol - crema vaginal - 100 mg/g - clotrimazol 100 mg - clotrimazol

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 500mg (micronised); clotrimazole 1%; clotrimazole 1%{relative} - combination - active: clotrimazole 500mg (micronised) excipient: calcium lactate, hydrate as pentahydrate colloidal silicon dioxide crospovidone hypromellose lactic acid lactose monohydrate magnesium stearate maize starch microcrystalline cellulose active: clotrimazole 1% excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate active: clotrimazole 1%{relative} excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate - canestan clotrimazole thrush 1 day pessary & cream is indicated for the topical treatment of vulvovaginal candidiasis. the cream can also be used in the management of candida vulvovaginitis or infection of the peri-anal area, while application of the cream to the glans penis of the partner may help prevent re-infection of the female.